81 results on '"Ilan, Yaron"'
Search Results
2. Constrained disorder principle-based variability is fundamental for biological processes: Beyond biological relativity and physiological regulatory networks
3. A second-generation artificial intelligence-based therapeutic regimen improves diuretic resistance in heart failure: Results of a feasibility open-labeled clinical trial
4. AN ARTIFICIAL INTELLIGENCE BASED THERAPEUTIC REGIMEN IMPROVES DIURETIC RESISTANCE IN HEART FAILURE
5. Making use of noise in biological systems
6. The constrained disorder principle defines living organisms and provides a method for correcting disturbed biological systems
7. A digital health platform for assisting the diagnosis and monitoring of COVID-19 progression: An adjuvant approach for augmenting the antiviral response and mitigating the immune-mediated target organ damage
8. Platform introducing individually tailored variability in nerve stimulations and dietary regimen to prevent weight regain following weight loss in patients with obesity
9. A synergistic effect of Ambroxol and Beta-Glucosylceramide in alleviating immune-mediated hepatitis: A novel immunomodulatory non-immunosuppressive formulation for treatment of immune-mediated disorders
10. Overcoming Compensatory Mechanisms toward Chronic Drug Administration to Ensure Long-Term, Sustainable Beneficial Effects
11. The assembly of glycosphingolipid determines their immunomodulatory effect: A novel method for structure-based design of immunotherapy
12. The role of chronobiology in drug-resistance epilepsy: The potential use of a variability and chronotherapy-based individualized platform for improving the response to anti-seizure drugs
13. Establishing patient-tailored variability-based paradigms for anti-cancer therapy: Using the inherent trajectories which underlie cancer for overcoming drug resistance
14. The role of microtubules in the immune system and as potential targets for gut-based immunotherapy
15. Prevention of acetaminophen-induced liver injury by alginate
16. Primary sclerosing cholangitis is associated with abnormalities in CFTR
17. 739 - A Novel Orally Administered Recombinant Anti-TNF Alpha Fusion Protein for the Treatment of Mild to Moderate Ulcerative Colitis: Results of a Phase 2A Clinical Trial Showing Promising Results
18. Biomarkers for Nonalcoholic Steatohepatitis
19. Liver involvement in Gaucher disease – Review and clinical approach
20. Combined beta-glucosylceramide and ambroxol hydrochloride in patients with Gaucher related Parkinson disease: From clinical observations to drug development
21. Successful use of streptokinase for the treatment of empyema thoracis during advanced pregnancy: A case report
22. An oral administration of a recombinant anti-TNF fusion protein is biologically active in the gut promoting regulatory T cells: Results of a phase I clinical trial using a novel oral anti-TNF alpha-based therapy
23. A plant cell-expressed recombinant anti-TNF fusion protein is biologically active in the gut and alleviates immune-mediated hepatitis and colitis
24. Tocilizumab Promotes Regulatory T-cell Alleviation in STAT3 Gain-of-function−associated Multi-organ Autoimmune Syndrome
25. Mo1881 Oral Administration of a Recombinant Anti-TNF Fusion Protein Is Biologically Active in the Gut Promoting Regulatory T Cells and Is a Novel Anti-TNF Alpha-Based Therapy for Inflammatory Bowel Diseases: Results of a Phase I Clinical Trial
26. Use of the methacetin breath test to classify the risk of cirrhotic complications and mortality in patients evaluated/listed for liver transplantation
27. Reduced liver cell death using an alginate scaffold bandage: A novel approach for liver reconstruction after extended partial hepatectomy
28. Tu2029 A novel method for anti-TNF based-oral immunotherapy: Oral administration of a plant cell-expressed recombinant anti-TNF fusion protein for treating of Crohn's disease
29. Mo1211 Oral Administration of Non-Absorbable Delayed Release 6-Mercaptopurine is Locally Active in the Gut, Exerts a Systemic Immune Effect and Alleviates Crohn's Disease With Low Rate of Side Effects: Results of Double Blind Phase II Clinical Trial
30. Reduced dose and duration of peginterferon alfa-2b and weight-based ribavirin in patients with genotype 2 and 3 chronic hepatitis C
31. S1860 The 13C Breath Test Identifies Decreased Beta-Oxidation and Improved Glucose Tolerance and Hepatic Impairment in Patients With Non Alcoholic Steatohepatitis After an Exercise and Diet Intervention
32. T1241 Promotion of CD4+CD25+FOXP3+ Regulatory Cells by Oral Administration of Locally Acting Delayed Release Low-Dose 6MP Formulation Alleviated Crohn's Disease: Results of Phase I/II Clinical Trial
33. Decreased STAT-1 phosphorylation by a thio analogue of beta-d-glucosylceramide is associated with altered NKT lymphocyte polarization
34. Oral tolerance: Can we make it work?
35. 747 Decision Making in Clinical Hepatology Using the 13C Methacetin Breath Test: Results of a 614 Patient Clinical Trial
36. T1198 Oral Administration of Alequel™, a Mixture of Autologous Colon-Extracted Proteins for Treatment of Crohn's Disease: Results of a Double-Blind Clinical Trial
37. M1264 The Non-Invasive 13C Octanoate Breath Test Accurately Assesses Hepatic Mitochondrial Beta Oxidation Before and After Bariatric Surgery
38. S1837 The Point of Care 13C Methacetin Breath Test Accurately Predicts Long Term Prognosis in Patients with Chronic Liver Disease: A Non Invasive Liver Function Test
39. S1648 Type II Non Classical NKT Lymphocytes Are Crucial for Alleviation of TNBS Induced Immune Colitis: A Role for the Alteration of Membrane Lipid Rafts On Dendritic Cells
40. β-Glycoglycosphingolipid-Induced Alterations of the STAT Signaling Pathways Are Dependent on CD1d and the Lipid Raft Protein Flotillin-2
41. OR.104. Induction of Regulatory T Cells by Mucosal Administration of Aryl Hydrocarbon Receptor Ligands and Anti-CD3 Monoclonal Antibody in Animals and Humans
42. Administration of β-glycolipids overcomes an unfavorable nutritional dependent host milieu: a role for a soy-free diet and natural ligands in intrahepatic CD8+ lymphocyte trapping and NKT cell redistribution
43. β-Glycosphingolipids-mediated lipid raft alteration is associated with redistribution of NKT cells and increased intrahepatic CD8+ T lymphocyte trapping
44. NKT lymphocyte polarization determined by microenvironment signaling: A role for CD8+ lymphocytes and β-glycosphingolipids
45. Modulation of intracellular machinery by β-glycolipids is associated with alteration of NKT lipid rafts and amelioration of concanavalin-induced hepatitis
46. 2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist, in various rat tissues during the evolution of experimental cholestatic liver disease
47. β-Glycoglycosphingolipid-induced augmentation of the anti-HBV immune response is associated with altered CD8 and NKT lymphocyte distribution: A novel adjuvant for HBV vaccination
48. 460 The 13c Methacetin Breath Test Accurately Identifies Liver Fibrosis in Patients with Chronic Hepatitis C Virus Infection: A Validation Study
49. Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC
50. Suppression of hepatocellular carcinoma growth in mice via leptin, is associated with inhibition of tumor cell growth and natural killer cell activation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.